
Healthcare · BSE
Star Imaging and Path Lab Limited, founded in 2004, is a healthcare company offering a wide range of diagnostic services, including radiology tests like X-rays, CT scans, MRIs, and ultrasounds, as well as pathology services such as blood tests, microbiology, PCR, and histopathology. With advanced equipment and skilled medical professionals, the company focuses on delivering accurate and timely results to support effective diagnosis and treatment. Operating across multiple regions, it serves both individual patients and healthcare institutions. As of September 30, 2024, the company employs 209 full-time staff, including executive directors.
Price Band
₹135 – ₹142
Issue Size
₹69.46 Cr
Lot Size
1000 shares
GMP
+3.5%
Est. Listing
₹147
at current GMP
Subscribed
5.67x
overall
Open
8 Aug 2025
Close
12 Aug 2025
Allotment
13 Aug 2025
Refund
14 Aug 2025
Demat Credit
15 Aug 2025
Listing
18 Aug 2025
Overall Subscription
5.67x
Total Demand
QIB Multiplier
12.85x
Institutions & Funds
NII / HNI
4.38x
High Net-Worth
Retail (RII)
2.31x
Individual Bidders
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 871,000 | 11,188,000 | 12.85x |
| NIB | 657,000 | 2,878,000 | 4.38x |
| HNIs(10L +) | 438,000 | 2,242,000 | 5.12x |
| HNIs (2-10L) | 219,000 | 636,000 | 2.90x |
| RETAIL | 1,528,000 | 3,532,000 | 2.31x |
| EMPLOYEES | 52,000 | 16,000 | 0.31x |
| Total | 3,765,000 | 20,492,000 | 5.67x |
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| QIB | — | 9 | 0.00x |
| NIB | — | 200 | 0.00x |
| RETAIL | 764 | 1,766 | 2.31x |
| EMPLOYEES | — | 5 | 0.00x |
| HNIs(10L +) | 146 | 257 | 1.76x |
| HNIs (2-10L) | 73 | 192 | 2.63x |
| Total Applications | 983 | 2,429 | 2.47x |
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
Star Imaging and Path Lab Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹69.46 Crores. The shares are offered at a price band of ₹135 to ₹142 per equity share on BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1000 shares (approx. ₹1,42,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Kfin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-08-15, while un-allotted funds or UPI block mandates will be released on 2025-08-14.
The latest Grey Market Premium (GMP) for Star Imaging and Path Lab Limited IPO is ₹5 per equity share. Based on the upper price band of ₹135 to ₹142 per equity share, the estimated listing price is ₹147 (+3.5% expected listing gain).
With a lot size of 1000 shares and current GMP of ₹5, the expected profit per application lot is approx ₹5,000 (+3.5% gain). Minimum application cost is approx ₹1,42,000.
The Star Imaging and Path Lab Limited IPO aggregate issue size is ₹69.46 Crores with an equity price band set at ₹135 to ₹142 per equity share. The retail lot size is 1000 shares requiring a minimum capital outlay of approx. ₹1,42,000.
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 5.67x (Retail: 2.31x, QIB: 12.85x, NII: 4.38x). You can track live multiples directly on our dedicated subscription page.
The basis of allotment will be published on the official registrar portal (Kfin Technologies Limited) and the BSE status verification website on or around 2025-08-13. Investors can verify status using PAN card or application number.
Star Imaging and Path Lab Limited shares are scheduled to list on BSE on 2025-08-18.